Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.20 is 133% above its 5-year average of -0.62, near the high end of its 5-year range (-3.95–0.29).
As of the fiscal period ended Tuesday, June 30, 2026. 9.02% below its 12-month average of 0.23.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.20.
DEBT TO EQUITY RATIO
0.20
DEBT TO EQUITY RATIO AVG TTM
0.23
DEBT TO EQUITY RATIO AVG 3Y
0.25
DEBT TO EQUITY RATIO AVG 5Y
-0.62
DEBT TO EQUITY RATIO AVG 10Y
-0.46
DEBT TO EQUITY RATIO AVG 15Y
-0.31
DEBT TO EQUITY RATIO AVG 20Y
-0.18
CURRENT VS TTM AVG
-9.02%
CURRENT VS 3Y AVG
-19.35%
CURRENT VS 5Y AVG
+132.85%
CURRENT VS 10Y AVG
+144.81%
CURRENT VS 15Y AVG
+165.73%
CURRENT VS 20Y AVG
+212.38%
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
+86.29%
vs the sector median at left
TherapeuticsMD, Inc.
Market Cap
$23.38M
Debt to Equity Ratio
0.20
TTM Avg
0.23
3Y Avg
0.25
5Y Avg
-0.62
Market Cap
$23.06M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.01
Market Cap
$24.44M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$22.25M
Debt to Equity Ratio
0.03
TTM Avg
0.04
3Y Avg
0.12
5Y Avg
0.10
Market Cap
$22.00M
Debt to Equity Ratio
0.51
TTM Avg
0.86
3Y Avg
0.77
5Y Avg
0.62
Market Cap
$25.22M
Debt to Equity Ratio
0.17
TTM Avg
1.46
3Y Avg
1.37
5Y Avg
1.15
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | $23.38M | 0.20 | 0.23 | 0.25 | -0.62 |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | 0.00 | 0.00 | 0.00 | 0.01 |
| LeonaBio, Inc. (LONA)vs › | $22.68M | 0.02 | 0.03 | 0.02 | 0.01 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | N/A | 0.00 | 0.00 | 0.19 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00 | 0.00 | 0.00 | 0.00 |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 0.03 | 0.04 | 0.12 | 0.10 |
| InspireMD, Inc. (NSPR)vs › | $24.69M | 0.06 | 0.06 | 0.06 | 0.07 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 0.51 | 0.86 | 0.77 | 0.62 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | 0.17 | 1.46 | 1.37 | 1.15 |
| NextCure, Inc. (NXTC)vs › | $20.84M | 0.35 | 0.12 | 0.08 | 0.06 |
Debt/Equity
0.20
Current Ratio
3.22
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.20 |
| 2026-03-31 | 0.22 |
| 2025-12-31 | 0.23 |
| 2025-09-30 | 0.24 |
| 2025-06-30 | 0.24 |
| 2025-03-31 | 0.26 |
| 2024-12-31 | 0.26 |
| 2024-09-30 | 0.27 |
| 2024-06-30 | 0.27 |
| 2024-03-31 | 0.27 |
| 2023-12-31 | 0.27 |
| 2023-09-30 | 0.29 |
| 2023-06-30 | 0.27 |
| 2023-03-31 | 0.27 |
| 2022-12-31 | 0.25 |
| 2022-09-30 | -2.12 |
| 2022-06-30 | -3.83 |
| 2022-03-31 | -1.51 |
| 2021-12-31 | -2.11 |
| 2021-09-30 | -3.40 |
| 2021-06-30 | -3.95 |
| 2021-03-31 | -20.31 |
| 2020-12-31 | -2.01 |
| 2020-09-30 | -2.14 |
| 2020-06-30 | -2.71 |
| 2020-03-31 | -5.62 |
| 2019-12-31 | 22.31 |
| 2019-09-30 | -9.60 |
| 2019-06-30 | 24.29 |
| 2019-03-31 | 1.26 |
| 2018-12-31 | 0.75 |
| 2018-09-30 | 0.55 |
| 2018-06-30 | 0.94 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 0.00 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | -2.50 |
| 2012-09-30 | -1.29 |
| 2012-06-30 | -5.03 |
| 2012-03-31 | -1.06 |
| 2011-12-31 | -1.26 |
| 2011-09-30 | -0.85 |
| 2011-06-30 | -0.88 |
| 2011-03-31 | -0.81 |
| 2010-12-31 | -0.83 |
| 2010-09-30 | 0.00 |
| 2010-06-30 | 0.00 |
| 2010-03-31 | -1.21 |
| 2009-12-31 | -1.93 |
| 2009-09-30 | 1.93 |
| 2009-06-30 | 0.00 |
| 2009-03-31 | 0.00 |
| 2008-12-31 | 0.00 |
| 2008-09-30 | 0.00 |
| 2008-06-30 | 0.00 |
| 2008-03-31 | 0.00 |
| 2007-12-31 | 0.00 |
| 2007-09-30 | 0.00 |
| 2007-06-30 | 0.00 |
| 2007-03-31 | 0.00 |
| 2006-12-31 | 0.00 |
| 2006-09-30 | 0.05 |
| 2006-06-30 | 0.06 |
| 2006-03-31 | 0.06 |
| 2005-12-31 | 0.06 |
| 2005-09-30 | 0.05 |
| 2005-06-30 | 0.00 |
| 2005-03-31 | 0.00 |
| 2004-12-31 | 0.00 |
| 2004-09-30 | 0.00 |
| 2004-06-30 | 0.00 |
| 2004-03-31 | 0.00 |
| 2003-12-31 | 0.00 |
| 2003-09-30 | 0.00 |
| 2003-06-30 | 0.00 |
| 2003-03-31 | 0.00 |
| 2002-12-31 | 0.00 |
| 2002-09-30 | 0.00 |
